S. Couty et al. / Tetrahedron 62 (2006) 3882–3895
3889
498 (6), 496 (6), 432 (7), 232 (10), 231 (100), 203 (30), 172
(7), 171 (88), 170 (8), 169 (91), 90 (13), 89 (9), 76 (15).
5.2.9. N-Allyl-N-ethynyl-2-iodobenzamide (7c). This
compound was synthesized from ynamide 6c (1.50 g,
3.90 mmol) by treatment with TBAF (5.1 mL, 1 M in
THF, 5.1 mmol, 1.3 equiv) in THF (50 mL), as described
for the preparation of 7a from 6a. The crude material was
purified by flash chromatography (petroleum ether/EtOAc:
70:30) to afford 1.03 g (85%) of 7c as a white powder; mp
55–57 8C; IR 3300, 2140, 1580, 1360, 1290, 1255, 1015,
5.2.6. N-Allyl-2-iodo-N-trimethylsilylethynyl-benzamide
(6c). This compound was prepared from 4c (2.50 g,
8.71 mmol), KHMDS (30.7 mL, 0.5 M in toluene,
15.3 mmol, 1.8 equiv) and iodonium salt 5 (7.53 g,
16.7 mmol, 1.9 equiv) in toluene (200 mL), as described
for the preparation of 6a from 4a. The crude material was
purified by flash chromatography (petroleum ether/EtOAc:
95:5–90:10) to afford 2.10 g (63%) of 6c as a white waxy
solid; mp !45 8C; IR 2180, 1665, 1585, 1360, 1290, 1250,
1
935, 770, 740 cmK1; H NMR d 7.83 (dd, JZ8.0, 0.7 Hz,
1H), 7.42–7.30 (m, 2H), 7.11 (apparent td, JZ7.7, 1.8 Hz,
1H), 5.99 (ddt, JZ16.6, 10.3, 6.3 Hz, 1H), 5.43 (dq, JZ
16.6, 1.5 Hz, 1H), 5.34 (dq, JZ10.3, 1.5 Hz, 1H), 4.31 (dt,
apparent br d, JZ6.3, 1.5 Hz, 2H), 2.64 (s, 1H); 13C NMR d
170.8 (s), 140.9 (s), 138.9 (d), 130.9 (d), 130.6 (d), 127.7
(d), 127.5 (d), 119.4 (t), 92.0 (s), 76.6 (s), 61.3 (d), 50.4 (t);
MS-EI m/z (relative intensity) 311 (MC, 4), 271 (15), 232
(8), 231 (100), 203 (33), 182 (5), 76 (24). Anal. Calcd for
C12H10INO: C, 46.33; H, 3.24; N, 4.50. Found: C, 46.68; H,
3.47; N, 4.29.
1
840, 760, 740 cmK1; H NMR d 7.81 (dd, JZ8.1, 0.9 Hz,
1H), 7.41–7.27 (m, 2H), 7.10 (ddd, JZ8.1, 7.4, 0.9 Hz, 1H),
5.98 (ddt, JZ16.5, 10.3, 6.2 Hz, 1H), 5.41 (dq, JZ16.5,
1.5 Hz, 1H), 5.32 (dq, JZ10.3, 1.5 Hz, 1H), 4.27 (dt, JZ
6.2, 1.5 Hz, 2H), K0.07 (s, 9H); 13C NMR d 171.1 (s),
141.4 (s), 138.7 (d), 130.8 (d), 130.6 (d), 127.6 (d, 2C),
119.3 (t), 96.0 (s), 92.1 (s), 75.6 (s), 50.1 (t), K0.29 (q, 3C);
MS-EI m/z (relative intensity) 383 (MC, 9), 368 (MKMeC,
17), 294 (6), 256 (13), 231 (100), 203 (28), 180 (6), 76 (17).
Anal. Calcd for C15H18INOSi: C, 47.00; H, 4.73; N, 3.65.
Found: C, 47.11; H, 4.74; N, 3.63.
5.2.10. N-Allyl-2-bromonicotinamide (10). This com-
pound was synthesized from 2-bromonicotinic acid 934
(2.0 g, 9.9 mmol) and allylamine (0.93 mL, 12.4 mmol,
1.25 equiv) in the presence of EDCI (2.3 g, 12 mmol,
1.2 equiv) and DMAP (0.12 g, 0.99 mmol, 0.1 equiv) in
CH2Cl2 (200 mL) as described for the preparation of 4a
from benzylamine and 2-iodobenzoic acid. After purifi-
cation by flash chromatography (diethyl ether), 1.25 g
(52%) of 10 were obtained as a white solid; mp 97–98 8C;
5.2.7. N-Benzyl-N-ethynyl-2-iodobenzamide (7a). To a
solution of 6a (70 mg, 0.16 mmol) in THF (5 mL) at 0 8C
was added tetra(n-butyl)ammonium fluoride (TBAF)
(0.21 mL, 1 M in THF, 0.21 mmol, 1.3 equiv). After
10 min at 0 8C, the reaction mixture was hydrolyzed with
a saturated aqueous solution of NH4Cl and extracted with
ether. The combined extracts were washed with brine, dried
over MgSO4, filtered and concentrated under reduced
pressure. The crude material was purified by flash
chromatography (petroleum ether/EtOAc: 90:10) to afford
56 mg (96%) of 7a as a pale yellow solid; mp 100–102 8C;
IR 3290, 2140, 1680, 1580, 1355, 1320, 1285, 1250, 1140,
1
IR 1660, 1580, 1395, 1300, 1055, 990, 930, 820 mK1; H
NMR d 8.31 (dd, JZ4.8, 1.8 Hz, 1H), 7.75 (dd, JZ7.7,
1.8 Hz, 1H), 7.27 (dd, JZ7.7, 4.8 Hz, 1H), 6.79 (br s, 1H,
NH), 5.86 (ddt, JZ17.3, 10.3, 5.9 Hz, 1H), 5.25 (dq, JZ
17.3, 1.5 Hz, 1H), 5.14 (dq, JZ10.3, 1.5 Hz, 1H), 3.99 (ddt,
apparent tt, JZ5.9, 1.5 Hz, 2H); 13C NMR d 165.6 (s), 150.7
(d), 138.3 (s), 138.0 (d), 134.7 (s), 133.0 (d), 122.6 (d),
116.9 (t), 42.4 (t); MS-EI m/z (relative intensity) 242
(M[81Br]C, 5), 240 (M[79Br]C, 5), 227 (20), 225 (20), 186
(97), 184 (100), 161 (23), 158 (30), 156 (31), 76 (17), 56 (6),
51 (7).
1
760, 730, 710, 695 cmK1; H NMR d 7.81 (dd, JZ8.1,
0.7 Hz, 1H), 7.52–7.46 (m, 2H), 7.42–7.28 (m, 5H), 7.10
(ddd, JZ8.1, 7.4, 1.8 Hz, 1H), 4.87 (s, 2H), 2.60 (s, 1H); 13C
NMR d 170.9 (s), 138.9 (s), 135.0 (s), 130.8 (d), 128.9 (d,
2C), 128.4 (d, 2C), 128.4 (s), 128.1 (d), 127.8 (d, 2C), 91.9
(s), 76.6 (s), 61.7 (d), 51.7 (t); MS-EI m/z (relative intensity)
361 (MC, 2), 232 (7), 231 (43), 203 (16), 91 (100), 76 (12).
5.2.11. N-Allyl-2-bromo-N-trimethylsilylethynyl-nicotin-
amide (11). This compound was synthesized from 10
(800 mg, 3.32 mmol), KHMDS (10.6 mL, 0.5 M in toluene,
5.3 mmol, 1.6 equiv) and iodonium salt 5 (2.39 g, 5.30 mmol,
1.6 equiv) in toluene (50 mL), as described for the preparation
of 6a from 4a. After purification by flash chromatography
(petroleum ether/EtOAc: 90:10), 643 mg (58%) of 11 were
obtained as a yellow oil; IR 2180, 1685, 1645, 1575, 1555,
1390, 1365, 1295, 1250, 1205, 1165, 1120, 1055, 990, 920,
840, 760, 705, 640 cmK1; 1H NMR d 8.42 (dd, JZ4.8, 1.9 Hz,
1H), 7.64 (dd, JZ7.7, 1.9 Hz, 1H), 7.32 (dd, JZ7.7, 4.8 Hz,
1H), 5.93 (ddt, JZ17.2, 10.3, 6.2 Hz, 1H), 5.40 (dq, JZ17.2,
1.1 Hz, 1H), 5.32 (dq, JZ10.3, 1.1 Hz, 1H), 4.27 (dt, JZ6.2,
1.1 Hz, 2H), K0.06 (s, 9H); 13C NMR d 168.0 (s), 150.5 (d),
138.5 (s), 136.5 (d), 134.5 (s), 130.3 (d), 122.1 (d), 119.6 (t),
95.4 (s), 76.3 (s), 50.2 (t), K0.35 (q, 3C); MS-EI m/z (relative
intensity) 338 (M[81Br]C, 15), 336 (M[79Br]C, 15), 323 (58),
321 (57), 257 (56), 249 (14), 247 (14), 186 (97), 185 (14), 184
(100), 180 (14), 158 (48), 156 (49), 139 (20), 137 (20), 84(14),
76(19), 73(18). Anal. Calcd for C14H17BrN2OSi: C, 49.85; H,
5.08; N, 8.31. Found: C, 49.89; H, 5.27; N, 8.27.
5.2.8. N-(2-Bromobenzyl)-N-ethynyl-2-iodobenzamide
(7b). This compound was synthesized from ynamide 6b
(600 mg, 1.17 mmol) by treatment with TBAF (1.53 mL,
1 M in THF, 1.53 mmol, 1.3 equiv) in THF (15 mL), as
described for the preparation of 7a from 6a. The crude
material was purified by flash chromatography (petroleum
ether/EtOAc: 90:10) to afford 408 mg (79%) of 7b as an
orange solid; mp 105–106 8C; IR 3300, 2150, 1690, 1585,
1350, 1295, 1030, 980, 770, 750 cmK1; 1H NMR d 7.86 (br
d, JZ8.1 Hz, 1H), 7.62 (br d, JZ8.1 Hz, 1H), 7.56 (dd, JZ
7.7, 1.5 Hz, 1H), 7.43–7.35 (m, 3H), 7.23 (dd, JZ7.7,
1.5 Hz, 1H), 7.15 (m, 1H), 5.04 (s, 2H), 2.55 (s, 1H); 13C
NMR d 171.0 (s), 140.8 (s), 139.2 (d), 134.2 (s), 133.0 (d),
131.2 (d), 130.3 (d), 129.6 (d), 127.9 (d), 127.8 (d), 127.5
(d), 124.0 (s), 92.2 (s), 76.5 (s), 62.2 (d), 51.4 (t); MS-EI m/z
(relative intensity) 271 (MCH–CH2(C6H4Br)C, 100), 243
(5), 242 (5), 215 (3), 116 (32), 89 (36), 88 (13), 63 (7), 62
(8). Anal. Calcd for C16H11BrINO: C, 43.67; H, 2.52; N,
3.18. Found: C, 43.89; H, 2.65; N, 3.06.